Watson Pharmaceuticals (WPI) Tops Q3 EPS by 4c; Updates FY11 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St set for lower open as hot inflation data fuels rate-hike bets
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q3 EPS of $1.09, $0.04 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.09 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- State Street (STT) Tops Q3 EPS by 2c
- Citigroup beats Q3 estimates as revenue hits decade high
- Evolution Metals reaffirms FY2027 revenue guidance of $400M-$460M
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
